Having held this stock since 2017/18 and exited entirely early 2024 it gives me little pleasure to see the SP revisit these levels again (apart from some questionable pumpers and loudmouths) well done to many of the old hands that done well by selling in the run up to 62c but tough on some who got fooled by the constant pumping of management. The question is what is ahead. In the absence of blockbuster news ( which I imagine to be far to early) do you wait for some pop up to claw back any sort of cash or wait in hope for something to happen. For the sake of the whole biotech sector I hope this does not turn out another OPT and cash becomes the problem. Time will tell
IMU Price at posting:
2.6¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)